serum tumescence

Objective To study the clinical value of serum tumor marker determination and whole body bone scan for diagnosis of bone metastases from breast cancer.

目的:探讨联检血清肿瘤标志物和放射性核素骨显像对诊断乳腺癌骨转移的临床价值。

Methods Serum tumor markers (CA153、CA125、CEA、FER ) were assayed with CLIA and whole body bone scan were investigated with SPECT on 174 breast cancer patients.

目的探讨血清肿瘤标志物预测乳腺癌骨转移的临床价值。

Purpose: To evaluate the combined application CT and serum tumor markers in diagnosis and staging ovarian carcinoma.

目的:评价CT和血清肿瘤标记物联合检查在卵巢癌诊断与分期中的价值。

Objective:To assess the value of combined testing of serum tumor markers in the diagnosis of gallbladder carcinoma.

目的 :观察胆囊癌患者血清肿瘤标记物的表达 ,分析血清肿瘤标记物联合检测在胆囊癌诊断中的作用。

Objective Carbohydrate antigen 50 (CA50) and 242 (CA242), recently recognized as serum tumor markers, are studied for their value in the diagnosis of the colorectal carcinoma.

结论CA50和CA242的血清水平在结直肠癌中比结直肠良性疾病中为高,在结直肠癌的晚期比早期为高,对结直肠癌的临床诊断具有一定价值,可和其他血清肿瘤标记物联合检测,互相弥补以提高检出率;也可通过动态观察其血清水平,推测患者病情的进展。

The volume of tumor size,the contents of serum tumor marker(Cyfra21.

培养特定天数后用测径器分析瘤体大小、生化分析仪检测血清肿瘤标示物(肺癌:Cyfra21。